US2011213029A1PendingUtilityA1
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
Est. expiryApr 16, 2021(expired)· nominal 20-yr term from priority
Inventors:Arthur G. TaverasCynthia AkiRichard BondJianping ChaoMichael P. DwyerJohan FerreiraJianhua ChaoYounong YuJohn J. BaldwinBernd KaiserGe LiJ. MerrittPurakkattle BijuKingsley NelsonLaura RokoszGaifa LaiJames P. JakwayMinglang WuEvan HeckerDaniel LundellJay Fine
A61P 37/06A61P 37/02A61P 9/12A61P 9/00A61P 9/10A61P 7/02A61P 29/00A61P 25/28A61P 31/12A61P 31/04A61P 35/00A61P 31/00A61P 25/00A61P 27/02A61P 27/16A61P 33/06A61P 31/14A61P 31/18A61P 11/06C07D 307/38A61P 1/04C07D 319/18A61P 1/16A61P 17/10C07D 333/20A61P 1/02A61P 19/06C07C 237/30C07D 213/74C07C 311/39C07D 413/12C07D 317/46A61P 17/06A61P 17/00C07D 307/52C07C 2601/14A61P 11/14C07D 295/26C07D 307/83C07C 237/36A61P 13/12C07D 413/14C07D 405/12A61P 19/02C07C 225/20C07D 307/81C07D 409/12C07C 2602/08C07D 307/82A61P 11/00C07D 207/335A61P 1/18C07D 217/24C07D 307/68C07D 333/36A61P 17/02C07C 255/59C07C 2601/04C07D 409/14C07C 237/44A61P 19/10C07D 333/42
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
Claims
exact text as granted — not AI-modified1 - 157 . (canceled)
158 . A method of treating COPD, comprising administering an effective amount of the compound
or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.
159 . A pharmaceutical composition, comprising the compound
or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is a capsule.Join the waitlist — get patent alerts
Track US2011213029A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.